ISRCTN27827390已完成不适用
Carboplatin versus etoposide/cisplatin for advanced metastatic seminoma
Medical Research Council (MRC) (UK)0 个研究点目标入组 112 人开始时间: 2001年2月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 112
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Histologically verified testicular/extra-gonadal pure seminoma
排除标准
- •Previous chemotherapy.
研究者
相似试验
已完成
2 期
Cisplatin/Etoposide or Paclitaxel/Carboplatin with Concurrent Radiation Therapy in Stage IIIB Non-Small Cell Lung Cancer: A One-Year Randomized Trial at a Low-Resource SettingC34.9Bronchus or lung, unspecifiedDRKS00012599Oncology & Radiotherapy Centre, Square Hospitals Ltd.60
招募中
3 期
To Compare Carboplatin/ Paclitaxel with Cisplatin/ Etoposide in advanced Non Small Cell Lung cancer (NSCLC).CTRI/2020/03/023770Tata Memorial Hospital
已完成
不适用
EfficAcy and safety of carboPlatin, etoposide and atezOlizumab for the first-line treatment of patients with extensive-stage smaLL cell lung cancer in the real-wOrld setting.Small cell lung cancerJPRN-UMIN000038064Wakayama Medical University208
进行中（未招募）
2 期
A phase II study of carboplatin and etopside plus durvalumab for previously-untreated extensive-stage small-cell lung cancer (ES-ECLC) patients with poor performance status (PS) - NEJ045Aextensive disease small cell lung cancerJPRN-jRCTs031200319Watanabe Satoshi56
招募中
2 期
A phase II study of atezolizumab plus chemotherapy for elderly patients with ED-SCLCSmall cell lung cancerJPRN-jRCTs041210002Takahashi Toshiaki40